Subscribe to RSS

DOI: 10.1055/s-0044-1790285
Intensive Oral Hygiene Interventions during Therapy of Acute Leukemia May Result in Detrimental Outcomes: A Randomized Clinical Trial
Authors
Abstract
Objectives
There are no standard guidelines on oro-dental care during induction therapy of acute leukemia (AL). This study aimed to assess the effect of intensive oral hygiene practice on oral mucositis, infection, and disease outcomes compared to standard clinical practice.
Materials and Methods
Newly diagnosed patients with AL were randomized to receive either standard oral hygiene protocol (group A, n = 92) or comprehensive oral hygiene protocol (group B, n = 91). In group A, the oral hygiene indexes were measured by the dentist at baseline and at the end of treatment. In group B, weekly monitoring of oral hygiene indexes by the dentist and interventions in the form of oral cavity inspection, probing for gum health, and use of a soft toothbrush and education on oral hygiene practices were carried out.
Results
The frequency of mucositis was higher in group B (60%) than in group A (40%; p = 0.09). There was no difference in the median Simplified Oral Hygiene Index (OHI-S; 0.5 vs. 0.6) and Silness and Loe plaque index (0.4 vs. 0.25) between the groups. The local (11 vs. 1%; p = 0.005) and systemic infection rate (82.2 vs. 65.2%; p = 0.009) were higher in group B than in group A.
Conclusion
This study failed to show the superiority of a comprehensive oral hygiene protocol compared to standard protocol in reducing oral mucositis in patients receiving induction therapy for AL. We hypothesize that frequent intervention in the oral cavity may lead to the dissemination of infection.
Authors' Contribution
B.D. made substantial contributions to the conception and design of the work, acquisition and interpretation of data for the work, drafting the work, and revising it critically for important intellectual content, and gave final approval of the version to be published. N.P.M. contributed to data acquisition and gave final approval of the version to be published. K.B. made substantial contributions to the conception and design of the work, acquisition of data, and revising the manuscript critically for important intellectual content, and gave final approval of the version to be published. S.K. made substantial contributions to the conception and design of the work, acquisition of data, and revising the manuscript critically for important intellectual content, and gave final approval of the version to be published. K.T.H.K. contributed to the analysis and interpretation of data for the work and gave final approval of the version to be published. M.A. contributed to data acquisition and gave final approval of the version to be published. N.D. contributed to data acquisition and gave final approval of the version to be published. P.G. contributed to revising the manuscript critically for important intellectual content and gave final approval of the version to be published. Y.N. contributed to the analysis and interpretation of data for the work, revising the manuscript critically, and drafting the work, and gave final approval of the version to be published.
All the authors agreed to be accountable for all aspects of the work and to ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Data and Code Availability
The datasets analyzed in this study are available with the corresponding author, which can be obtained on reasonable request. The datasets generated or analyzed during the current study are available from the corresponding author on reasonable request.
Ethical Approval and Consent to Participate
This study was approved by the JIPMER Institute ethics committee (JIP/IEC/2016/28/931). All data used in this study were anonymized and coded before use. Written informed consent was obtained from each participant after explaining the purpose and procedure and their contribution in the study in their vernacular language.
Publication History
Received: 02 February 2024
Accepted: 09 August 2024
Article published online:
18 September 2024
© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Radhakrishnan V, Bakhshi S, Kayal S. et al. Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial. Blood Cancer J 2022; 12 (09) 131
- 2 Advani S, Pai S, Venzon D. et al. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. Ann Oncol 1999; 10 (02) 167-176
- 3 Bajel A, George B, Mathews V. et al. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer 2008; 51 (05) 621-625
- 4 Ganesan P, Sagar TG, Kannan K. et al. Acute lymphoblastic leukemia in young adults treated with intensive “pediatric” type protocol. Indian J Hematol Blood Transfus 2018; 34 (03) 422-429
- 5 Kapoor G, Goswami M, Sharma S, Mehta A, Dhillon JK. Assessment of oral health status of children with leukemia: a cross-sectional study. Spec Care Dentist 2019; 39 (06) 564-571
- 6 McMahon S, Sahasrabhojane P, Kim J. et al. Contribution of the oral and gastrointestinal microbiomes to bloodstream infections in leukemia patients. Microbiol Spectr 2023; 11 (03) e0041523
- 7 Xavier AM, Hegde AM. Preventive protocols and oral management in childhood leukemia: the pediatric specialist's role. Asian Pac J Cancer Prev 2010; 11 (01) 39-43
- 8 Lowal KA, Alaizari NA, Tarakji B, Petro W, Hussain KA, Altamimi MAA. Dental considerations for leukemic pediatric patients: an updated review for general dental practitioner. Mater Sociomed 2015; 27 (05) 359-362
- 9 Chaveli López B, Gavaldá Esteve C, Sarrión Pérez MG. Dental treatment considerations in the chemotherapy patient. J Clin Exp Dent 2011; 3 (01) e31-e42
- 10 Khanjani Pour-Fard-Pachekenari A, Rahmani A, Ghahramanian A, Asghari Jafarabadi M, Onyeka TC, Davoodi A. The effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trial. Clin Oral Investig 2019; 23 (04) 1811-1821
- 11 Cammarata-Scalisi F, Girardi K, Strocchio L. et al. Oral manifestations and complications in childhood acute myeloid leukemia. Cancers (Basel) 2020; 12 (06) 12
- 12 Ponce-Torres E, Ruíz-Rodríguez Mdel S, Alejo-González F, Hernández-Sierra JF, Pozos-Guillén Ade J. Oral manifestations in pediatric patients receiving chemotherapy for acute lymphoblastic leukemia. J Clin Pediatr Dent 2010; 34 (03) 275-279
- 13 Cugini C, Ramasubbu N, Tsiagbe VK, Fine DH. Dysbiosis from a microbial and host perspective relative to oral health and disease. Front Microbiol 2021; 12: 617485
- 14 Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 1994; 30B (02) 93-97
- 15 Wong HM. Oral complications and management strategies for patients undergoing cancer therapy. ScientificWorldJournal 2014; 2014: 581795
- 16 Toth BB, Martin JW, Fleming TJ. Oral complications associated with cancer therapy. An M. D. Anderson Cancer Center experience. J Clin Periodontol 1990; 17 (7, Pt 2): 508-515
- 17 Bui FQ, Almeida-da-Silva CLC, Huynh B. et al. Association between periodontal pathogens and systemic disease. Biomed J 2019; 42 (01) 27-35
